20 articles
Clinical trial investigated whether pressurized oxygen treatments could stimulate new blood vessel growth in elderly participants.
Systematic review reveals hyperbaric oxygen therapy improved bone density and strength through multiple biological pathways in rats.
A miniaturized PEMF device failed to raise SpO2 in healthy rats, suggesting COVID-19 benefits may be disease-specific.
Breakthrough therapy targeting hypoxic-ischemic encephalopathy in newborns receives significant funding, potentially becoming first HIE drug.
New hydrogen-releasing gel therapy successfully reversed osteoarthritis progression and repaired cartilage damage in animal studies.
A completed multicenter feasibility trial evaluates BTM, a novel biodegradable scaffold, for treating serious deep burn injuries.
New study compares two regenerative therapies for knee osteoarthritis, offering alternatives to steroid injections.
Comprehensive review examines peptides like BPC-157 and TB-500 for wound healing, muscle repair, and recovery optimization in orthopedic medicine.
New research reveals inhaled nitric oxide at high concentrations safely eliminates drug-resistant bacteria in lungs.
Small trial tests autologous bronchial stem cells to repair damaged lung tissue in chronic obstructive pulmonary disease patients.
Austrian researchers tracked heart attack patients for 5 years after receiving bone marrow cell therapy to assess long-term cardiac outcomes.
Small trial tests blood-derived therapy for persistent post-surgical ear infections that resist standard treatments.
Autologous stem cell injections tested in patients with severe leg circulation problems who had no surgical options.
A novel bone-mimicking scaffold delivering low-dose rhBMP-2 achieved complete fracture union in 4 months in a medically complex elderly patient.
Scientists engineer high-PS procoagulant platelets that outperform thrombin and commercial hemostatic agents, even in antiplatelet-treated patients.
AstraZeneca's baxdrostat wins FDA approval for hypertension, offering a novel mechanism for patients uncontrolled on existing therapies.
Packaging mitochondria in erythrocyte-derived membranes dramatically improves delivery efficiency, pushing this experimental therapy closer to clinical reality.
Study shows intensive glucose management increases cardiac stem cells in heart attack patients, potentially improving recovery.
65-patient trial tested bone marrow stem cells injected directly into damaged heart muscle to restore function in chronic heart failure.
Comprehensive review reveals how PRP's growth factors, immune cells, and exosomes work together to enhance tissue repair across multiple medical specialties.
